comprehensive -WSS

comprehensive

author：knowledge 2025-10-02 22:26:59 - browse：58

Venture firms backing health tech startups are telegraphing cautious optimism for 2024, advising startups to expect smaller and fewer checks as well as possible market consolidation but not to abandon hope just yet as investments stabilize following a sharp drop-off.

As customers — often health systems, payers, or employers — and backers plot how they’ll invest shrinking budgets, they’re increasingly savvy about metrics, investors told STAT. They’re also less interested in rapid growth, and more keen on startups that can demonstrate savings and efficiency.

That’s a sharp contrast from the unrestrained health tech investments that peaked in 2021, fueled by a pandemic-era frenzy for virtual appointments, mental health care and app-based therapies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban
Next article： The biotech scorecard for Q1: 17 stock

explore

WSS

U.K. Biobank has 500,000 peoples' genome sequences available

The EPA's new lead rule: How one expert crunched the numbers

U.K. Biobank has 500,000 peoples' genome sequences available

J&J to buy cancer drug developer Ambrx Biopharma

BIO selects John Crowley as new CEO

Disappointing trial forces Pfizer to pivot on obesity medicine plans

hotspot

comprehensive

focus

Medical records are filled with copy

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

Anesthesiologist group: stop taking Ozempic before surgery

GSK Flovent asthma inhalers replaced by authorized generics

23andMe had bad news about my health. I wish a person had delivered it

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

Jerome Adams on the need for new antivirals for Covid

The EPA's new lead rule: How one expert crunched the numbers

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

J&J to emphasize cancer drugs, stop much of its vaccine research

Wikipedia

Chronically ill young patients struggle to find fertility info

J&J to emphasize cancer drugs, stop much of its vaccine research

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

As biotech industry slumps, bioscience job market is upside down

What to do when lifesaving products contribute to climate change

Diagnostic tests are hitting their mathematical limits

hotspot

explore

explore

entertainment